TP53 and neoplasm: However, there are some reports showing that p53 inactivation does not lead to increased resistance to oxaliplatin (Seo et al, 2002; Petit et al, 2003), suggesting that the role of p53 in the cellular response to oxaliplatin may be tumour dependent.